AVNS (Avanos Medical) Total Inventories : $138.8 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Avanos Medical Total Inventories?

Avanos Medical's total inventories for the quarter that ended in Dec. 2024 was $138.8 Mil. Avanos Medical's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was $150.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Avanos Medical's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-1.15.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Avanos Medical's Days Inventory for the three months ended in Dec. 2024 was 168.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. Avanos Medical's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.54.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Avanos Medical's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.84.

Avanos Medical Total Inventories Historical Data

The historical data trend for Avanos Medical's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avanos Medical Total Inventories Chart

Avanos Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

168.90

159.30

132.30

163.20

138.80

Avanos Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial															163.20	165.60	163.90	161.90	138.80

Avanos Medical Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Avanos Medical (NYSE:AVNS) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Avanos Medical's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(107.7	+	0.75 * 127.9	+	0.5 * 138.8	-	325.7
-	0	-	0)	/	45.963
=	-1.15

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Avanos Medical's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	150.35	/	81.6	*	365 / 4
	=	168.13

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Avanos Medical's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	81.6	/	150.35
	=	0.54

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Avanos Medical's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	150.35	/	179.6
	=	0.84

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Avanos Medical Total Inventories Related Terms

Thank you for viewing the detailed overview of Avanos Medical's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Avanos Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avanos Medical Inc (NYSE:AVNS) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

8HH:Germany

Address

5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004

Website

https://www.avanos.com

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Executives

Kerr Holbrook	officer: SVP, GM Chronic Care	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Michael Greiner	officer: SVP - Chief Financial Officer	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421
Julie Ann Shimer	director	18453 LAS CUMBRES ROAD, LOS GATOS CA 95033
Sudhakar Varshney	officer: SVP, Global Supply Chain	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
John Joseph Hurley	officer: Principal Accounting Officer	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Patrick J Oleary	director	31515 BALLANTYNE CORP, C/O SPX CORP, CHARLOTTE NC 28277
Mojirade James	officer: SVP, General Counsel	5405 WINDWARD PKWY, ALPHARETTA GA 30004
William David Haydon	officer: SVP, GM Pain Franchise	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
David Edward Ball	officer: SVP - Global Supply Chain	AVANOS MEDICAL, INC., 5405 WINDWARD PKWY, ALPHARETTA GA 30004
Arjun Ranjan Sarker	officer: Senior VP, International	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Gary Blackford	director	7700 FRANCE AVENUE SOUTH, EDINA MN 55435
Joseph Fralin Woody	director, officer: Chief Executive Officer	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Steven E Voskuil	officer: See Remarks	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John W Wesley	director	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004